Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic reviewBiochemical characterization of uracil phosphoribosyltransferase from Mycobacterium tuberculosisImpacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer.Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer.The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric CancerMetabolomics in the fields of oncology: a review of recent research.Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancerTOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC studyVariants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients.A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis.
P2860
Q21146752-C6FF1D63-D943-4BFF-BA02-4C2FA4E42BD9Q26824719-939EE88D-1FC0-4869-85E1-93FA4E014C4FQ28486128-CF19C5E8-F4FC-48E6-B590-802D6C94D538Q33317139-4CB238CC-D11B-47E7-94BA-E6CD98F204E5Q33903541-35271CB7-AEED-4956-8061-5EC374220089Q34168437-38CBE89E-35A0-41D9-97C4-85EF5E879496Q34414547-64299AA4-A613-4514-B54B-A45801536A4DQ35126769-F60D0CF9-C984-4553-A6FB-7DAF2EF80C21Q35615776-99B97433-F4E7-4136-8E05-8BBDC5C4A592Q35878616-F43427B1-D056-4F55-BA54-FF6294C603D9Q37640119-B3E256F4-332E-4C69-BEC8-10036A364D34Q37660522-0A0AE30B-4B37-43E6-B275-7E37706EAF0AQ37986476-734FAAAC-6D22-486C-A4A4-63FA47227960Q38602962-7A122F51-2B76-4969-95ED-50B15B6F43FEQ41340592-B713AE4C-D65E-41FA-8B96-7AD5400AABA8Q42916637-B6740129-9D69-42DA-8404-4BD0DDEFFAB9Q55025912-34BF8900-99AB-4040-AB3D-2C87056C1FDA
P2860
Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@ast
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@en
type
label
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@ast
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@en
prefLabel
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@ast
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@en
P1433
P1476
Prediction of clinical outcome ...... luorouracil metabolic pathway.
@en
P2093
Wataru Ichikawa
P2888
P304
P356
10.1007/S10120-006-0373-8
P577
2006-01-01T00:00:00Z